Skip to main content
. 2022 Dec 14;11(24):7419. doi: 10.3390/jcm11247419

Table 3.

Differences between patients with and without comorbidity according to clinical evaluation.

Comorbidity
(n = 24)
No Comorbidity
(n = 54)
Test Statistics
Mean (SD) Mean (SD) z p Cohen’s d
Age 28.2 (12.2) 23.5 (6.7) −1.141 0.254 0.440
Years of illness 7.3 (7.5) 5.7 (6.4) −1.246 0.213 0.226
BMI 14.9 (2.3) 15.2 (2.9) 0.318 0.751 0.116
EDE-Q restraint 3.8 (1.9) 3.1 (2.0) −1.248 0.212 0.336
EDE-Q eating concerns 3.6 (1.7) 2.8 (1.4) −2.521 0.012 0.554
EDE-Q shape concerns 4.4 (1.6) 3.9 (1.5) −1.252 0.210 0.305
EDE-Q weight concerns 4.1 (1.6) 3.3 (1.9) −1.626 0.104 0.422
EDE-q global score 3.9 (1.6) 3.3 (1.5) −1.770 0.077 0.397
STAI-state 61.6 (11.7) 53.7 (13.2) −2.261 0.024 0.611
STAI-trait 60.6 (10.1) 55.6 (16.7) −1.164 0.244 0.400
BDI 20.0 (7.7) 15.6 (10.4) −2.486 0.013 0.520

BMI = Body Mass Index; EDE-Q = Eating Disorder Examination Questionnaire; STAI = State-Trait Anxiety Inventory; BDI = Beck Depression Inventory. Cohen’s d values: negligible effect: d = −0.15–0.15; small effect: d = 0.15–0.40; medium effect: d = 0.40–0.75; large effect: d = 0.75–1.10; very large effect: d = 1.10–1.45; huge effect: d = 1.45.